Muscular Dystrophy

Clinical Trial Open for Patients With Limb-Girdle Muscular Dystrophy Type 2E

Researchers are investigating the safety and effectiveness of a new gene therapy product that replaces the defective β-sarcoglycan gene.
March 4, 2019  |  Written by